149 related articles for article (PubMed ID: 11119731)
1. Failure of the combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels.
Eviö S; Tiitinen A; Turpeinen U; Ylikorkala O
Fertil Steril; 2000 Dec; 74(6):1080-3. PubMed ID: 11119731
[TBL] [Abstract][Full Text] [Related]
2. The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane.
Ylikorkala O; Cacciatore B; Paakkari I; Tikkanen MJ; Viinikka L; Toivonen J
Fertil Steril; 1998 May; 69(5):883-8. PubMed ID: 9591497
[TBL] [Abstract][Full Text] [Related]
3. Comparison between 1 year oral and transdermal oestradiol and sequential norethisterone acetate on circulating concentrations of leptin in postmenopausal women.
Laivuori H; Koistinen HA; Karonen SL; Cacciatore B; Ylikorkala O
Hum Reprod; 2001 Aug; 16(8):1632-5. PubMed ID: 11473954
[TBL] [Abstract][Full Text] [Related]
4. Effects of low-dose 17-beta-estradiol plus norethisterone acetate and tibolone on fasting plasma homocysteine levels in postmenopausal women.
Kaleli B; Yildirim B; Demir S; Alatas E
Acta Obstet Gynecol Scand; 2003 Dec; 82(12):1107-11. PubMed ID: 14616255
[TBL] [Abstract][Full Text] [Related]
5. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
Kurtay G; Ozmen B; Erguder I
Maturitas; 2006 Jan; 53(1):32-8. PubMed ID: 16325022
[TBL] [Abstract][Full Text] [Related]
6. Positive effects on cardiovascular and breast metabolic markers of oral estradiol and dydrogesterone in comparison with transdermal estradiol and norethisterone acetate.
Campagnoli C; Colombo P; De Aloysio D; Gambacciani M; Grazioli I; Nappi C; Serra GB; Genazzani AR
Maturitas; 2002 Apr; 41(4):299-311. PubMed ID: 12034517
[TBL] [Abstract][Full Text] [Related]
7. Effects of norethisterone acetate addition to estradiol in long term HRT.
Li C; Samsioe G; Wilaman K; Lidfelt J; Nerbrand C; Agardh CD; Schersten B
Maturitas; 2000 Aug; 36(2):139-52. PubMed ID: 11006501
[TBL] [Abstract][Full Text] [Related]
8. Effects of transdermal and oral hormone replacement therapies on monocyte chemoattractant protein-1 levels: a randomized clinical trial.
Taşçı T; Şükür YE; Özmen B; Atabekoğlu CS; Cengiz SD; Koçbulut E; Berker B; Sönmezer M
Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():50-4. PubMed ID: 24655552
[TBL] [Abstract][Full Text] [Related]
9. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
Johannisson E; Holinka CF; Arrenbrecht S
Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effect of oral and transdermal hormone therapy on fasting and postmethionine homocysteine levels.
Cagnacci A; Malmusi S; Zanni AL; Alessandrini C; Caretto S; Volpe A
Fertil Steril; 2004 Jan; 81(1):99-103. PubMed ID: 14711550
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms.
Saure A; Hirvonen E; Milsom I; Christensen A; Damber MG
Maturitas; 1996 May; 24(1-2):111-8. PubMed ID: 8794442
[TBL] [Abstract][Full Text] [Related]
12. A randomized placebo-controlled study of the effect of transdermal vs. oral estradiol with or without gestodene on homocysteine levels.
Smolders RG; van der Mooren MJ; Teerlink T; Merkus JM; Kroeks MV; Franke HR; Stehouwer CD; Kenemans P
Fertil Steril; 2003 Feb; 79(2):261-7. PubMed ID: 12568832
[TBL] [Abstract][Full Text] [Related]
13. Continuous combined hormone replacement therapy with oral 17beta-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women.
Ventura P; Cagnacci A; Malmusi S; Panini R; Baldassari F; Arangino S; Volpe A; Salvioli G
Menopause; 2001; 8(4):252-8. PubMed ID: 11449082
[TBL] [Abstract][Full Text] [Related]
14. Efficacy on climacteric symptoms of a continuous combined regimen of 1 mg 17beta-estradiol and trimegestone versus two regimens combining 1 or 2 mg 17beta-estradiol and norethisterone acetate.
Gambacciani M; Spielmann D; Genazzani AR
Gynecol Endocrinol; 2005 Aug; 21(2):65-73. PubMed ID: 16294457
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women.
Yilmazer M; Fenkci V; Fenkci S; Sonmezer M; Aktepe O; Altindis M; Kurtay G
Maturitas; 2003 Dec; 46(4):245-53. PubMed ID: 14625121
[TBL] [Abstract][Full Text] [Related]
16. Continuous, combined hormone replacement: randomized comparison of transdermal and oral preparations.
Mattsson LA; Bohnet HG; Gredmark T; Torhorst J; Hornig F; Hüls G
Obstet Gynecol; 1999 Jul; 94(1):61-5. PubMed ID: 10389719
[TBL] [Abstract][Full Text] [Related]
17. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol and norethisterone acetate. A two-year follow-up study.
Rosselli M; Imthurn B; Keller PJ; Jackson EK; Dubey RK
Hypertension; 1995 Apr; 25(4 Pt 2):848-53. PubMed ID: 7721443
[TBL] [Abstract][Full Text] [Related]
18. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
Samsioe G; Dvorak V; Genazzani AR; Hamann B; Heikkinen J; Mueck AO; Suzin J; Kawakami FT; Ferreira A; Sun D; Arguinzoniz M
Maturitas; 2007 Jun; 57(2):171-81. PubMed ID: 17317046
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
Chiantera V; Sarti CD; Fornaro F; Farzati A; De Franciscis P; Sepe E; Borrelli AL; Colacurci N
Menopause; 2003; 10(4):286-91. PubMed ID: 12851511
[TBL] [Abstract][Full Text] [Related]
20. Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application.
Mueck AO; Genazzani AR; Samsioe G; Vukovic-Wysocki I; Seeger H
Menopause; 2007; 14(6):978-84. PubMed ID: 17595593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
